Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -7.95% is 819% below its 5-year average of -0.87%, near the low end of its 5-year range (-7.95%–2.67%).
As of the fiscal period ended Wednesday, December 31, 2025. 100.76% below its 12-month average of -3.96%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
-7.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-3.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-1.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-0.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
0.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
3.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
3.87%
CURRENT VS TTM AVG
-100.76%
CURRENT VS 3Y AVG
-568.07%
CURRENT VS 5Y AVG
-819.08%
CURRENT VS 10Y AVG
-2029.61%
CURRENT VS 15Y AVG
-341.78%
CURRENT VS 20Y AVG
-305.67%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-193.20%
vs the sector median at left
Viatris Inc.
Market Cap
$20.55B
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-3.96%
3Y Avg
-1.19%
5Y Avg
-0.87%
Market Cap
$22.03B
Return on Invested Capital (ROIC)
16.13%
TTM Avg
15.79%
3Y Avg
14.56%
5Y Avg
13.09%
Market Cap
$18.99B
Return on Invested Capital (ROIC)
5.48%
TTM Avg
5.58%
3Y Avg
5.01%
5Y Avg
3.94%
Market Cap
$22.32B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$22.68B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
Market Cap
$23.16B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$16.97B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
8.59%
3Y Avg
9.78%
5Y Avg
13.56%
Market Cap
$24.28B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
Market Cap
$16.41B
Return on Invested Capital (ROIC)
67.94%
TTM Avg
52.59%
3Y Avg
46.08%
5Y Avg
35.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $20.55B | -7.95% | -3.96% | -1.19% | -0.87% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 16.13% | 15.79% | 14.56% | 13.09% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.99B | 5.48% | 5.58% | 5.01% | 3.94% |
| Moderna, Inc. (MRNA)vs › | $22.32B | -29.70% | -31.12% | -12.69% | 0.19% |
| STERIS plc (STE)vs › | $22.68B | 8.47% | 7.82% | 7.13% | 6.49% |
| BioNTech SE (BNTX)vs › | $23.16B | -3.14% | -4.79% | 9.55% | 20.42% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| Incyte Corporation (INCY)vs › | $24.28B | 20.58% | 10.42% | 9.36% | 7.13% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 67.94% | 52.59% | 46.08% | 35.95% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 13.62% | 14.65% | 16.90% | 17.70% |
ROIC
-8.0%
ROE
-2.0%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -7.95% |
| 2024-12-31 | 0.03% |
| 2023-12-31 | 0.49% |
| 2022-12-31 | 2.67% |
| 2021-12-31 | -0.07% |
| 2020-12-31 | -0.36% |
| 2019-12-31 | 0.29% |
| 2018-12-30 | 3.14% |
| 2017-12-30 | 3.55% |
| 2016-12-30 | 2.33% |
| 2015-12-30 | 7.07% |
| 2014-12-30 | 9.74% |
| 2013-12-30 | 7.45% |
| 2012-12-31 | 8.75% |
| 2011-12-31 | 8.40% |
| 2010-12-31 | 7.08% |
| 2009-12-31 | 5.64% |
| 2008-12-31 | 3.31% |
| 2007-12-31 | 3.75% |
| 2006-03-31 | 12.00% |
| 2005-03-31 | 10.41% |
| 2004-03-31 | 18.96% |
